Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/29956
Title: | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency : An Open-Label, Group Comparison, Dose-Escalation Trial |
Authors: | Csаkvаry, Violetta Ammer, Nicola Bagci, Ekaterine Bolshova, Olena Damholt, Birgitte Bentz Katanic, Dragan Mikhailova, Evgenia Muzsnai, Ágota Radu, Dmitri Senatorova, Ganna Szalecki, Mieczysław Teifel, Michael Vajda, Zsolt Zelinska, Nataliya Chaychenko, Tetyana |
Keywords: | Growth hormone deficiency Macimorelin tolerability |
Issue Date: | 2021 |
Citation: | Csаkvаry V. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency : An Open-Label, Group Comparison, Dose-Escalation Trial [Електронний ресурс] / V. Csаkvаry, N. Ammer, E. B. Bagci, O. V. Bolshova, B. B. Damholt, D. Katanic, E. Mikhailova, А. Muzsnai, D. Raduk, G. Senatorova, M. Szalecki, M. Teifel, Z. Vajda, N. Zelinska, T. Chaychenko // Hormone Research in Paediatrics. – 2021. – DOI: 10.1159/000519232. |
Abstract: | Diagnosis of growth hormone deficiency (GHD) in children requires the use of provocative growth hormone (GH) stimulation tests, which can have limited reliability and are potentially contraindicated in some patients. This is the first paediatric study to test the safety, tolerability, and pharmacokinetics (PK)/pharmacodynamics (PD) of macimorelin, an oral GH secretagogue, approved for diagnosis of adult GHD. Methods: In this open-label, group com parison, single-dose escalation trial (EudraCT 2018-00198823), sequential cohorts of patients (C1–C3) received ascending single doses of macimorelin: 0.25 (C1), 0.5 (C2), and 1.0 (C3) mg/kg. Primary endpoints were safety and tolerability, and secondary endpoints were PK/PD. Results: Twenty-four patients aged between 2 and <18 with suspected GHD participated in the study. No macimorelin-related adverse events were reported, and macimorelin was well tolerated. |
URI: | https://repo.knmu.edu.ua/handle/123456789/29956 |
Appears in Collections: | Наукові праці. Кафедра педіатрії № 1 та неонатології |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Безопасность, переносимость, фармакокинетика и фармакодинамика макиморелина у детей.pdf | 427,25 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.